The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study
2011

DDAH1 Gene Polymorphism and Type 2 Diabetes

Sample size: 814 publication Evidence: moderate

Author Information

Author(s): Lu Tse-Min, Lin Shing-Jong, Lin Ming-Wei, Hsu Chiao-Po, Chung Ming-Yi

Primary Institution: Taipei Veterans General Hospital

Hypothesis

The study investigates the association between DDAH1 gene polymorphisms and type 2 diabetes.

Conclusion

SNP rs1241321 in DDAH1 is associated with type 2 diabetes and its long-term outcomes.

Supporting Evidence

  • Only SNP rs1241321 was significantly associated with a decreased risk of type 2 diabetes.
  • The AA genotype of rs1241321 was linked to lower fasting plasma glucose levels.
  • Over 28 months, the AA genotype was associated with reduced risk of major adverse cardiovascular events.

Takeaway

Scientists found a gene change that might help explain why some people get type 2 diabetes and how it affects their health over time.

Methodology

The study analyzed 814 subjects, including 309 type 2 diabetic patients and 505 non-diabetic individuals, assessing six SNPs in DDAH1 and measuring plasma ADMA levels.

Potential Biases

Potential bias due to the exclusion of patients with severe comorbidities and the specific population studied.

Limitations

The study population was limited to individuals undergoing coronary angiography, which may not represent the general population.

Participant Demographics

Participants included 309 type 2 diabetic patients and 505 non-diabetic individuals, primarily older adults.

Statistical Information

P-Value

p = 0.004

Confidence Interval

95% CI 0.47-0.86

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-2840-10-16

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication